The National Multiple Sclerosis Society is pumping $17 million into 43 research projects that represent almost half of its $40-million research funding commitment in 2017. Among the projects are trials evaluating intermittent fasting as a way to harness inflammation and stem cell research. A growing number of studies indicate that stem cells can slow MS activity and repair the damage
April 11, 2016 Spectator Health reporter Injecting adult stem cells into the heart could potentially halve the number of deaths from heart failure, a study has suggested. The study, published in the Lancet, found that patients who received the treatment had a 37 per cent lower rate of death and hospitalisation for heart failure-related problems.
Cardio-Thoracic Surgery Patients Receive Regenerative Medicine Treatment to Reduce Scarring, Speed Wound Healing
Therapeutic Rallies Body's Stem Cells for Natural Tissue Repair CLEVELAND, April 18, 2013 /PRNewswire-USNewswire/ -- SironRX Therapeutics Inc. (SironRX), a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose